Osceola, IN, United States of America

Steven C Charlton

Average Co-Inventor Count = 2.3

ph-index = 21

Forward Citations = 4,062(Granted Patents)

Forward Citations (Not Self Cited) = 3,831(Sep 21, 2024)

DiyaCoin DiyaCoin 11.12 

Inventors with similar research interests:


Location History:

  • Elkhart, IN (US) (1985 - 1996)
  • Osceloa, IN (US) (2011)
  • Oceola, IN (US) (2014)
  • Osceola, IN (US) (1990 - 2022)


Years Active: 1985-2022

where 'Filed Patents' based on already Granted Patents

95 patents (USPTO):
25 patents (CIPO):

Title: Innovator Spotlight: Steven C. Charlton - Pioneering Analyte Sensor Technologies

Introduction: Steven C. Charlton, a prolific inventor hailing from Osceola, IN, has significantly contributed to the field of bio-fluid analysis with his groundbreaking patents. With an impressive portfolio of 95 patents, Charlton's work showcases his innovative spirit and dedication to advancing healthcare technologies.

Latest Patents: Among Charlton's latest patents is the groundbreaking invention of temperature sensing analyte sensors. These sensors are designed to detect analyte concentration levels in bio-fluid samples with unparalleled accuracy. By integrating thermocouple technology into the sensors, Charlton has enabled on-sensor temperature measurement capabilities, revolutionizing the field of biosensor technology. Additionally, his invention of determining analyte concentration from variant concentration distribution in measurable species has opened new possibilities for electrochemical analyte detection without the limitations of Cottrell decay.

Career Highlights: Charlton has made significant contributions during his tenure at renowned companies such as Bayer Healthcare LLC and Ascensia Diabetes Care Holdings Ag. His expertise and innovative mindset have driven advancements in healthcare diagnostics, particularly in the field of diabetes management. Charlton's relentless pursuit of excellence has earned him a reputation as a visionary in the field of bio-fluid analysis.

Collaborations: Throughout his career, Charlton has collaborated with esteemed professionals such as Andrew J. Edelbrock and Sung-Kwon Jung. These collaborations have been instrumental in refining his inventions and bringing cutting-edge technologies to the market. Charlton's ability to foster collaborations and synergies underscores his commitment to driving innovation in the healthcare industry.

Conclusion: Steven C. Charlton's innovative contributions to analyte sensor technologies have had a profound impact on bio-fluid analysis and healthcare diagnostics. His pioneering work continues to inspire generations of inventors and researchers to push the boundaries of what is possible in the field of biosensor technology. Charlton's legacy as a visionary inventor is firmly established, and his innovative spirit will undoubtedly shape the future of healthcare technologies for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…